Safety and Tolerability of Lamotrigine for Bipolar Disorder
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 27 (3) , 173-184
- https://doi.org/10.2165/00002018-200427030-00002
Abstract
Tolerability and safety are important considerations in optimising pharmacotherapy for bipolar disorder. This paper reviews the tolerability and safety of lamotrigine, an anticonvulsant recommended...Keywords
This publication has 50 references indexed in Scilit:
- Self-Reported Adherence to Treatment With Mood Stabilizers, Plasma Levels, and Psychiatric HospitalizationAmerican Journal of Psychiatry, 2002
- Extending Indications for Long-Term Pharmacotherapy: Opportunities and ChallengesAmerican Journal of Psychiatry, 2002
- Double-Blind, Placebo-Controlled Comparison of Imipramine and Paroxetine in the Treatment of Bipolar DepressionAmerican Journal of Psychiatry, 2001
- Bodyweight Gain and AnticonvulsantsDrug Safety, 2001
- A Placebo-Controlled Study of Lamotrigine and Gabapentin Monotherapy in Refractory Mood DisordersJournal of Clinical Psychopharmacology, 2000
- LamotrigineEpilepsia, 1999
- Carbamazepine Toxicity with Lamotrigine: Pharmacokinetic or Pharmacodynamic Interaction?Epilepsia, 1998
- Induction of Mania With Serotonin Reuptake InhibitorsJournal of Clinical Psychopharmacology, 1996
- Addition of Lamotrigine to Valproate May Enhance Efficacy in the Treatment of Bipolar Affective DisorderPharmacopsychiatry, 1996
- Intractable Epilepsy in Children. The Efficacy of Lamotrigine Treatment, Including Non-Seizure-Related BenefitsNeuropediatrics, 1994